Barclays PLC vs Oscar Health Inc — how do they compare? Barclays PLC trades at $28.1 (market cap $94.10B), while Oscar Health Inc trades at $27.89 (market cap $8.54B). The key difference: Barclays PLC is far larger — about 11× Oscar Health Inc's market cap, and Barclays PLC pays a 2.18% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| BCS | OSCR | |
|---|---|---|
Market Cap | $94.10B | $8.54B |
Sector | Financials | Health |
52-Week High | $28.56 | $32.18 |
52-Week Low | $19.36 | $10.85 |
Dividend Yield | 2.18% | — |
Enterprise Value | — | $4.90B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OSCR trades at $27.90, up 5.12% with strong recent earnings performance including Q2 2026 EPS beating estimates. The stock shows bearish technical signals but positive fundamental momentum with revenue growth from $11.7B to $15.3B and a swing to profitability. Recent news highlights record 2026 profitability and raised full-year guidance.
The outlook appears constructive with analyst consensus target of $32.50 offering 16% upside. Key risks include execution on growth targets and competitive pressures. The valuation remains attractive with P/S of 0.53, though investors should monitor Q3 earnings delivery against expectations.
Trailing returns across standard periods
Latest headlines on both assets
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →